Methotrexate Pfizer

Methotrexate, the active ingredient in Methotrexate Pfizer, is an antimetabolite (folate antagonist) presented as a 10 mg/mL injectable solution for intra‑arterial, intramuscular, intravenous use. It treats rheumatoid arthritis, psoriasis, acute lymphoblastic leukemia, non‑Hodgkin lymphoma, and ectopic pregnancy in appropriate patients.

GNH USA supplies Methotrexate Pfizer as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, and pharmacies worldwide.

Methotrexate is used across several disease families, primarily as an antimetabolite that interferes with cell proliferation. - Rheumatoid arthritis: reduces joint inflammation and slows disease progression. - Psoriasis: improves skin lesions and decreases plaque formation. - Acute lymphoblastic leukemia: induces remission by inhibiting malignant cell proliferation. - Non‑Hodgkin lymphoma: contributes to tumor control when used in combination regimens. - Ectopic pregnancy: terminates trophoblastic tissue non‑surgically.

Methotrexate may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea and vomiting. - Fatigue or general weakness. - Oral mucosal ulceration (mouth sores). - Transient elevation of liver enzymes. - Decreased white blood cell count. - Mild rash or itching.

Serious or Rare Side Effects: - Severe hepatotoxicity or liver fibrosis. - Pulmonary fibrosis or interstitial pneumonitis. - Profound bone marrow suppression leading to infection or bleeding. - Acute renal failure. - Life‑threatening skin reactions such as Stevens‑Johnson syndrome. - Anaphylactic or severe hypersensitivity reactions.

Before initiating therapy, several safety considerations are recommended. - Liver Monitoring: perform baseline and periodic liver function tests. - Hematologic Surveillance: regularly check complete blood counts. - Pregnancy Avoidance: contraindicated in pregnancy; ensure effective contraception. - Folic Acid Supplementation: co‑administer to reduce mucosal and hematologic toxicity. - Renal Function Adjustment: modify dose in patients with impaired renal clearance. - Store at ambient temperature: keep in original packaging, protect from moisture and light.

Methotrexate interacts with several medicines that may alter its efficacy or toxicity.

Major Interactions (Avoid): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): increase risk of renal and gastrointestinal toxicity. - Trimethoprim‑sulfamethoxazole: potentiates myelosuppression. - Live vaccines: heightened risk of infection due to immunosuppression.

Moderate Interactions (Monitor Closely): - Azathioprine: additive immunosuppressive effect, monitor blood counts. - Phenytoin: may reduce methotrexate plasma levels, adjust dosing if needed. - Alcohol: exacerbates hepatic toxicity, advise limited intake.